Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Jesús Mauricio Olivares-Gazca"'
Autor:
Miguel Antonio López-Trujillo Bsc, Jesús Mauricio Olivares-Gazca MD, Yahveth Cantero-Fortiz MD, Yarely Itzayana García-Navarrete MD, Antonio Cruz-Mora MD, Juan Carlos Olivares-Gazca MD, Iván Murrieta-Álvarez MD, Andrés Aurelio León-Peña MD, Guillermo J. Ruiz-Delgado MD, FACP, Guillermo J. Ruiz-Argüelles MD, FACP FRCP (Glasg), MACP, DSc (hon)
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Thrombocytopenia (less than 100 × 10 9 /L platelets) presents in around one quarter of patients with nonalcoholic fatty liver disease (NAFLD), the hepatic component of insulin resistance (IR). It is unknown whether IR, by itself, associates with thr
Externí odkaz:
https://doaj.org/article/1af3c1b0ff2647e987f52c2c0231dfcf
Autor:
Brizeida Azamar-Solis MD, Yahveth Cantero-Fortiz MD, Juan Carlos Olivares-Gazca MD, Jesús Mauricio Olivares-Gazca MD, Gisela Berenice Gómez-Cruz MD, Iván Murrieta-Álvarez MD, Guillermo J. Ruiz-Delgado MD, FACP, Guillermo J. Ruiz-Argüelles MD, MACP, FRCP(Glasg), DSc (Hon)
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
The sticky platelet syndrome (SPS) is a common cause of both arterial and venous thrombosis, being a dominant autosomal disease with qualitative platelet alterations and familial occurrence. It is characterized by platelet hyperreactivity with increa
Externí odkaz:
https://doaj.org/article/d545a541cd58428a8629d9207a0a15d1
Autor:
Jesús Mauricio Olivares-Gazca, Guillermo J Ruiz-Argüelles, Juan Carlos Olivares-Gazca, Andrés A. León-Peña, Sofía Banck-Angulo, Guillermo J. Ruiz-Delgado, Iván Murrieta-Álvarez, Gisela B. Gomez-Cruz, Griselda Fuentes-Fuentes, Yahveth Cantero-Fortiz, Danitza Fernández-Lara, Kassandra Pérez-Turrent
Publikováno v:
Revista Medicina Universitaria. 21
Autor:
Iván Murrieta-Álvarez, Jesús Mauricio Olivares-Gazca, Antonio Cruz-Mora, Juan Carlos Olivares-Gazca, Guillermo J. Ruiz-Delgado, Yahveth Cantero-Fortiz, Andrés Aurelio León-Peña, Miguel Antonio López-Trujillo, Guillermo J. Ruiz-Argüelles, Yarely Itzayana García-Navarrete
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Clinical and Applied Thrombosis/Hemostasis
Clinical and Applied Thrombosis/Hemostasis
Thrombocytopenia (less than 100 × 109/L platelets) presents in around one quarter of patients with nonalcoholic fatty liver disease (NAFLD), the hepatic component of insulin resistance (IR). It is unknown whether IR, by itself, associates with throm
Autor:
Jesús Mauricio Olivares-Gazca, Andrés A. León-Peña, Iván Murrieta-Álvarez, Yarely Itzayana García-Navarrete, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles, Luisa Fernanda Sánchez-Valledor, Antonio Cruz-Mora, Yahveth Cantero-Fortiz, Juan Carlos Olivares-Gazca
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S360
Introduction Multiple sclerosis (MS) is an inflammatory, demyelinating and neurodegenerative disease of the central nervous system (CNS) that causes a whole spectrum of neurological disorders associated with a profound decrease in the quality of life
Autor:
Juan Carlos Olivares-Gazca, Yarely Itzayana García-Navarrete, Iván Murrieta-Álvarez, Alejandro Ruiz-Argüelles, Lizsonette Medina de Jesús, Jesús Mauricio Olivares-Gazca, Andrés A. León-Peña, Guillermo J. Ruiz-Argüelles, Luisa Fernanda Sánchez-Valledor, Antonio Cruz-Mora, Yahveth Cantero-Fortiz, Guillermo J. Ruiz-Delgado, David P. Steensma
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S243
Introduction The treatment of patients with multiple myeloma (MM) has evolved in recent years, and the disease-associated prognosis has improved substantially. This improvement has been driven largely by the approval of novel agents, many of which ar
Autor:
Jesús Mauricio Olivares-Gazca, Iván Murrieta-Álvarez, Andrés A. León-Peña, Juan Carlos Olivares-Gazca, Yahveth Cantero-Fortiz, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles, Yarely Itzayana García-Navarrete
Publikováno v:
Blood. 134:5708-5708
Introduction Multiple sclerosis (MS) is an inflammatory, demyelinating and neurodegenerative disease of the central nervous system (CNS) that causes a whole spectrum of neurological disorders associated with a profound decrease in the quality of life
Autor:
David P. Steensma, Juan Carlos Olivares-Gazca, Yahveth Cantero-Fortiz, Guillermo J. Ruiz-Argüelles, Jesús Mauricio Olivares-Gazca, Andrés A. León-Peña, Antonio Cruz-Mora, Guillermo J. Ruiz-Delgado, Alejandro Ruiz-Argüelles, Iván Murrieta-Álvarez, Yarely Itzayana García-Navarrete
Publikováno v:
Blood. 134:5707-5707
Background The treatment of patients with multiple myeloma (MM) has evolved in recent years, and the disease-associated prognosis has improved substantially. This improvement has been driven largely by the approval of novel agents, many of which are
Autor:
Andrés A. León-Peña, Yahveth Cantero-Fortiz, Iván Murrieta-Álvarez, Juan Carlos Olivares-Gazca, Jesús Mauricio Olivares-Gazca, Yarely Itzayana García-Navarrete, Guillermo J. Ruiz-Delgado, María Fernanda Vallejo-Villalobos, Guillermo J. Ruiz-Argüelles
Publikováno v:
Annals of Blood. 4:15-15
Background: Sticky platelet syndrome (SPS) is a common but under-recognized cause of thrombosis. Treatment with antiplatelet drugs results in a low re-thrombosis rate. The aim of this study is to analyze the treatment of persons with SPS in different
Autor:
Guillermo J. Ruiz-Argüelles, María Fernanda Vallejo-Villalobos, Juan Carlos Olivares-Gazca, Guillermo J. Ruiz-Delgado, Gisela B. Gomez-Cruz, Jesús Mauricio Olivares-Gazca, Andrés A. León-Peña, Alejandro Ruiz-Argüelles
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S319
Background In an effort to reset the immune system, individuals with multiple sclerosis (MS) have undergone autologous hematopoietic stem cell transplant; this approach has produced promising results in terms of feasibility, efficacy and safety, howe